29 Immune modulation and baseline biomarker correlation with clinical benefit following treatment with COM701+nivolumab+/-BMS-986207 in patients with platinum resistant ovarian can... by Yu Liang, Gady Cojocaru, Inbal Barbiro, Zurit Levine, Eran Ophir, Zoya Alteber, Pierre Ferre, Assaf Wool, Roy Granit, Adi Shuchami

Procedures for behavioral experiments in head-fixed mice. by Zengcai V Guo, S Andrew Hires, Nuo Li, Daniel H O'Connor, Takaki Komiyama, Eran Ophir, Daniel Huber, Claudia Bonardi, Karin Morandell, Diego Gutnisky, Simon Peron, Ning-long Xu, James Cox, Karel Svoboda

Get full text

640 The combination of COM701 + nivolumab demonstrates preliminary antitumor activity in patients with metastatic breast cancer by Gady Cojocaru, Inbal Barbiro, Manish Patel, Manish Sharma, Dale Shepard, Drew Rasco, Bartosz Chmielowski, Kyriakos P Papadopoulos, Eran Ophir, Ecaterina Dumbrava, Erika Hamilton, Pierre Ferre, Daniel Vaena, Judy S Wang, Adeboye H Adewoye

669 Durable responses with triple blockade of the DNAM-1 axis with COM701 + BMS-986207 + nivolumab in patients with platinum resistant ovarian cancer by Gady Cojocaru, Inbal Barbiro, Amita Patnaik, Manish Sharma, Drew Rasco, Benjamin Izar, Kyriakos P Papadopoulos, Eran Ophir, Ryan Sullivan, Pierre Ferre, Stéphanie Gaillard, Daniel Vaena, Oladapo Yeku, John Moroney, Adeboye H Adewoye

550 Harnessing natural IL-18 activity through IL-18BP blockade reshapes the tumor microenvironment for potent anti-tumor immune response by Gady Cojocaru, Tal Fridman Kfir, Eran Ophir, Zoya Alteber, Pierre Ferre, Masha Frenkel, Assaf Menachem, Dan Blat, Olga Leiderman, Moran Galperin, Lital Sever, Nadav Cohen, Keren Cohen, Roy Granit, Sandra Vols, Lior Faigenbloom, Liron Soffer, Karin Meyer, Keren Menachem, Hadas Galon Tilleman, Michal Perpinial, Evgeny Tatirovsky